CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 158 filers reported holding CLOVIS ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $17,000 | -73.0% | 14,133 | -59.8% | 0.00% | – |
| Q2 2022 | $63,000 | -6.0% | 35,183 | +5.6% | 0.00% | – |
| Q1 2022 | $67,000 | -27.2% | 33,313 | -1.5% | 0.00% | – |
| Q4 2021 | $92,000 | -43.6% | 33,813 | -7.4% | 0.00% | – |
| Q3 2021 | $163,000 | -52.1% | 36,503 | -37.8% | 0.00% | – |
| Q2 2021 | $340,000 | -46.5% | 58,685 | -35.1% | 0.00% | -100.0% |
| Q1 2021 | $635,000 | +133.5% | 90,405 | +59.8% | 0.00% | – |
| Q4 2020 | $272,000 | +44.7% | 56,580 | +75.4% | 0.00% | – |
| Q3 2020 | $188,000 | +27.0% | 32,253 | +47.1% | 0.00% | – |
| Q2 2020 | $148,000 | -36.5% | 21,928 | +328.0% | 0.00% | -100.0% |
| Q2 2018 | $233,000 | -19.1% | 5,123 | -6.2% | 0.00% | 0.0% |
| Q1 2018 | $288,000 | +29.1% | 5,461 | +66.6% | 0.00% | 0.0% |
| Q4 2017 | $223,000 | +5.2% | 3,277 | +27.7% | 0.00% | 0.0% |
| Q3 2017 | $212,000 | -3.2% | 2,567 | +9.6% | 0.00% | 0.0% |
| Q2 2017 | $219,000 | – | 2,343 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |